NASDAQ:NRC - Nasdaq - US6373722023 - Common Stock - Currency: USD
NATIONAL RESEARCH CORP
NASDAQ:NRC (1/24/2025, 4:30:01 PM)
17.96
-0.09 (-0.5%)
The current stock price of NRC is 17.96 USD. In the past month the price increased by 0.67%. In the past year, price decreased by -55.21%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 10.68 | 81.68B | ||
CVS | CVS HEALTH CORP | 8.59 | 68.65B | ||
LH | LABCORP HOLDINGS INC | 17.06 | 20.58B | ||
DGX | QUEST DIAGNOSTICS INC | 17.57 | 17.33B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 14.66 | 14.45B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 171.68 | 14.05B | ||
DVA | DAVITA INC | 19.18 | 13.96B | ||
CHE | CHEMED CORP | 24.05 | 8.25B | ||
HIMS | HIMS & HERS HEALTH INC | 70.16 | 6.74B | ||
CRVL | CORVEL CORP | 24.23 | 5.86B | ||
GH | GUARDANT HEALTH INC | N/A | 5.83B | ||
OPCH | OPTION CARE HEALTH INC | 25.49 | 5.16B |
National Research Corp. engages in the provision of analytics and insights that facilitate patient, employee, and customer retention. The company is headquartered in Lincoln, Nebraska and currently employs 435 full-time employees. Its digital solutions consist of three primary solution categories: Marketing, Reputation and Experience. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools to evaluate the needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. The firm's Experience solutions are provided on a subscription basis via a cross-continuum multi-mode digital platform. Its Reputation solutions allow healthcare organizations to share a picture of their organization.
NATIONAL RESEARCH CORP
1245 Q Street
Lincoln NEBRASKA 68508 US
CEO: Michael D. Hays
Employees: 435
Company Website: http://nrchealth.com/
Phone: 14024752525
The current stock price of NRC is 17.96 USD.
The exchange symbol of NATIONAL RESEARCH CORP is NRC and it is listed on the Nasdaq exchange.
NRC stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for NRC, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of NRC.
NRC has a dividend yield of 2.78%. The yearly dividend amount is currently 1.49.
The PE ratio for NRC is 14.37. This is based on the reported non-GAAP earnings per share of 1.25 and the current share price of 17.96 USD.
ChartMill assigns a technical rating of 1 / 10 to NRC. When comparing the yearly performance of all stocks, NRC is a bad performer in the overall market: 90.32% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to NRC. NRC has an excellent profitability rating, but there are some minor concerns on its financial health.
Over the last trailing twelve months NRC reported a non-GAAP Earnings per Share(EPS) of 1.25. The EPS increased by -3.12% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 18.78% | ||
ROA | 20.54% | ||
ROE | 78.2% | ||
Debt/Equity | 1.44 |
ChartMill assigns a Buy % Consensus number of 45% to NRC. The Buy consensus is the average rating of analysts ratings from 8 analysts.